Evidence map›Paper›PMID 22223224›Full record

ArticleAdvanced materials (Deerfield Beach, Fla.)2012

Kinetically assembled nanoparticles of bioactive macromolecules exhibit enhanced stability and cell-targeted biological efficacy.

Adam W York, Kyle R Zablocki, Daniel R Lewis, Li Gu, Kathryn E Uhrich, Robert K Prud'homme, Prabhas V Moghe

Abstract read
In one paragraph

Article in Advanced materials (Deerfield Beach, Fla.), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Theranostic Nanoparticles for Fluorosensitive Visualization and Inhibition of Amyloid Beta-Induced Neuroinflammation.Particle & particle systems characterization : measurement and description of particle properties and behavior in powders and other disperse systems · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Control of polymeric nanoparticle size to improve therapeutic delivery.Journal of controlled release : official journal of the Controlled Release Society · 2015
    Review
  13. Designing polymers with sugar-based advantages for bioactive delivery applications.Journal of controlled release : official journal of the Controlled Release Society · 2015
    Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Sugar-based amphiphilic nanoparticles arrest atherosclerosis in vivo.Proceedings of the National Academy of Sciences of the United States of America · 2015
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Adam W YorkDepartment of Biomedical Engineering, Rutgers University, Piscataway, NJ 08854, USA.
Kyle R Zablocki
Daniel R Lewis
Li Gu
Kathryn E Uhrich
Robert K Prud'homme
Prabhas V Moghe

Funding

UMDNJ TRAINING GRANT IN BIOTECHNOLOGYT32GM008339 · NIGMS · RUTGERS THE ST UNIV OF NJ NEW BRUNSWICK · PI YARMUSH, MARTIN L · 1989 to 2019
$6.1M
Translational Research in Regenerative MedicineT32EB005583 · NIBIB · RUTGERS, THE STATE UNIV OF N.J. · PI LEE, KIBUM, PAREKKADAN, BIJU · 2006 to 2022
$4.7M
Synthetic Counter-ligands for Inhibition of AtherosclerosisR01HL107913 · NHLBI · RUTGERS, THE STATE UNIV OF N.J. · PI MOGHE, PRABHAS V, UHRICH, KATHRYN ELIZABETH · 2011 to 2014
$2.3M
Nanoscale Receptor Blockers for Inhibition of AtherosclerosisR21HL093753 · NHLBI · RUTGERS, THE STATE UNIV OF N.J. · PI MOGHE, PRABHAS V · 2009 to 2010
$671k
NHLBI NIH HHS R01 HL107913NHLBI NIH HHS R01HL107913NHLBI NIH HHS R21 HL093753NHLBI NIH HHS R21HL93753NIBIB NIH HHS T32 EB005583NIGMS NIH HHS T32 GM008339
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Biological TransportHumansHydrophobic and Hydrophilic InteractionsKineticsLipoproteins, LDLMacromolecular SubstancesMacrophagesNanoparticlesNanotechnologyLipoproteins, LDLMacromolecular Substancesoxidized low density lipoprotein

Identifiers

PMID22223224
PMCPMC3495129

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.